Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hemolink delivers significant oxygen, says study:

This article was originally published in Clinica

Executive Summary

The oxygen-carrying characteristics of Hemosol's blood substitute, Hemolink, are similar to those of fresh blood, according to the results of an in vitro study. The speed by which Hemolink retrieved and delivered oxygen was fast and appeared to coincide with the normal blood process, said Canadian researchers, who presented the findings at last week's American Society of Hematology meeting in Orlando, Florida. "This study is further confirmation of Hemolink's ability to retrieve oxygen in the lungs and immediately, efficiently and safely deliver it to the body's organs to treat acute anaemia," added Toronto-based Hemosol.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT074358

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel